GE nabs U-Systems

Editorial Staff | | Health Imaging | Oncology Imaging

GE Healthcare has acquired U-Systems, a manufacturer of ultrasound products designed for breast imaging. Financial terms were not disclosed.

With operations in Sunnyvale, Calif., and Phoenix, U-Systems has developed the somo•v Automated Breast Ultrasound (ABUS), an ultrasound system that is FDA-approved for breast cancer screening as an adjunct to mammography for asymptomatic women with greater than 50 percent dense breast tissue and no prior breast interventions.

According to a published study in the New England Journal of Medicine, women with dense tissue in 75 percent or more of the breast have a risk of breast cancer four to six times as great as the risk among women with little or no dense tissue. (New England Journal of Medicine 2007;356:227-36M).

The somo•v ABUS received FDA approval in September for breast cancer screening in the U.S., and also has been indicated for screening in Canada and the European Union.

Editorial Staff

Related Content

MRI-first approach could allow many to safely forego prostate biopsy
MRI guidance significantly reduces radiotherapy side effects compared to CT
Interventional procedure often as effective as surgery for difficult-to-treat liver cancer
AI tumor volume estimations could improve prostate cancer treatment strategies
MRI could be 'powerful tool' for guiding surgery decisions in patients with rectal cancer
Breast cancer only visible via MRI is often less aggressive

Around the web

Cardiovascular Business
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.